Aktuellt
SENASTE
Redeye provides a short comment on yesterday’s news regarding the evaluation of a new generation of the TRANBERG Thermal Therapy System for MRI-US, fusion-guided laser ablation for the minimally-invasive, targeted focal therapy of prostate tumours. We see this as yet another positive event for CLS and see an upside potential of some 73% to our Base Case.
LÄS MER
